E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
Rutgers, The State University of New Jersey
Rutgers, The State University of New Jersey
Sumitomo Pharma America, Inc.
National Institutes of Health Clinical Center (CC)
MacroGenics
Novartis
Brigham and Women's Hospital
National Institutes of Health Clinical Center (CC)
University of Pittsburgh
Incyte Corporation
LigaChem Biosciences, Inc.
Merck Sharp & Dohme LLC
UNICANCER
Institut Claudius Regaud
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
Instituto do Cancer do Estado de São Paulo
UNICANCER
Sotio Biotech Inc.
The Affiliated Hospital of Qingdao University
SCG Cell Therapy Pte. Ltd.
Corregene Biotechnology Co., Ltd
HRYZ Biotech Co.
Dana-Farber Cancer Institute
Xencor, Inc.
National Institutes of Health Clinical Center (CC)
Institut de Cancérologie de Lorraine
Rubius Therapeutics
Xencor, Inc.
Genocea Biosciences, Inc.
Corregene Biotechnology Co., Ltd
Institut de Cancérologie de Lorraine
Karolinska Institutet
Boston Medical Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Oryx GmbH & Co. KG
Traws Pharma, Inc.
Eli Lilly and Company
National Cancer Institute (NCI)
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center